Literature DB >> 35656801

Video and telephone teledermatology consultations during COVID-19 in comparison: patient satisfaction, doubts and concerns.

Angelo Ruggiero1, Matteo Megna1, Gabriella Fabbrocini1, Fabrizio Martora1.   

Abstract

Entities:  

Year:  2022        PMID: 35656801      PMCID: PMC9347843          DOI: 10.1111/ced.15286

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   4.481


× No keyword cloud information.
Dear Editor, Teledermatology represented one of the most important tools during the COVID‐19 pandemic, allowing physicians to continue caring for patients while avoiding the risk of infection for both. , To overcome restrictions on face‐to‐face (F2F) visits during the pandemic, we expanded our teledermatology services for patients, increasing the number of consultations through these services and also increasing the type of services available for patients. In particular, we used video‐call and phone‐call consultations and email support for patients, to ensure continuity of care as much as possible, especially for patients with chronic skin diseases requiring long‐term treatment and follow‐up, such as psoriasis or hidradenitis suppurativa. , We report our findings using a questionnaire‐based study evaluating patient satisfaction about the use of teledermatology. An eight‐item questionnaire was created to investigate patient opinion of our teledermatology services. Patients consulting at our clinic through teledermatology services were consecutively included in the study. Each enrolled patient was asked to anonymously complete a questionnaire after the consultation. In total, 265 patients were consecutively enrolled in the study. However, 13 were excluded from the study due to incomplete questionnaires. Hence, a total of 252 fully completed questionnaires were assessed (Table 1).
Table 1

Questionnaire and patients' answers (both video‐ and phone‐based consultations).

QuestionnaireType of consultation
VideoPhone
Clinical and demographic data
Gender
Male5369
Female4783
Age (years)
18–353070
36–453535
46–654525
> 65324
Condition
Acne9843
Psoriasis5550
Hidradenitis suppurativa3013
Alopecia (any type)2518
Other2319
Patient satisfaction
Rate your satisfaction for the teledermatology service (1–3unsatisfied; 4–6 satisfied; 7–10 very satisfied)
1–34765
4–611580
7–10150157
Would you choose teledermatology for future consultations?
Yes168198
No11454
Do you consider a teledermatology consultation as satisfactory as aface‐to‐face visit?
Yes5240
No200212
Do you have any concerns about teledermatology?
Yes178182
No4440
If you answered ‘Yes’ to the previous question, what concerns do you have?
Privacy (photo, video)6240
I feel uncomfortable with this technology3238
I feel uncomfortable receiving a prescription by teledermatology2234
I prefer a face‐to‐face visit6270
Questionnaire and patients' answers (both video‐ and phone‐based consultations). Interestingly, we found high levels of satisfaction using both video‐ and phone‐based teledermatology services. Patients using video‐based consultations were more (but not significantly) satisfied than phone‐based consultations, reporting that they will use this service in the future. Another interesting finding was that most of patients reporting satisfaction with the teledermatology services, both video‐ and phone‐based consultations, were younger patients with acne or chronic skin diseases (psoriasis and hidradenitis suppurativa), whereas older patients reported that they would prefer an F2F visit. , However, despite the high satisfaction level, most of the interviewed patients did not consider a teledermatology consultation as satisfactory as an F2F visit. This may be influenced by the platform used, difficulties that patients (especially older patients) may have using such technology, and privacy concerns. Teledermatology had a central role during the COVID‐19 pandemic, which led to marked development of this type of service, resulting in widespread use and high satisfaction rates reported by both patients and physicians. However, despite the widespread escalation of this technology, there are still major difficulties, such as privacy concerns and medicolegal issues, as an official and widely accepted form of informed consent during such consultations is lacking, as well as the absence of specified and safe online teledermatology platforms, which may represent obstacles to the further utilization and application of this useful service. Hence, official guidelines and recommendations are urgently needed to improve these services and increase the safety of and satisfaction with teledermatology consultations for patients and dermatologists.
  6 in total

1.  Teledermatology and chronic skin diseases: Real life experience in a Southern Italian Dermatologic Centre.

Authors:  Alessia Villani; Matteo Megna; Massimiliano Scalvenzi; Gabriella Fabbrocini; Angelo Ruggiero
Journal:  Dermatol Ther       Date:  2020-06-15       Impact factor: 2.851

2.  Teledermatology during COVID-19: a comparison of video and telephone visits with patient-uploaded images at an urban academic medical center.

Authors:  Liesl M Schroedl; Grace Y Duan; Arlene Ruiz De Luzuriaga
Journal:  Dermatol Online J       Date:  2022-01-15

3.  Safety of dupilumab in atopic patients during COVID-19 outbreak.

Authors:  Maddalena Napolitano; Cataldo Patruno; Angelo Ruggiero; Mariateresa Nocerino; Gabriella Fabbrocini
Journal:  J Dermatolog Treat       Date:  2020-06-19       Impact factor: 3.359

4.  Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral center of Southern Italy.

Authors:  Claudio Marasca; Angelo Ruggiero; Matteo Megna; Maria Carmela Annunziata; Gabriella Fabbrocini
Journal:  J Dermatolog Treat       Date:  2020-05-25       Impact factor: 3.359

5.  May COVID-19 outbreaks lead to a worsening of skin chronic inflammatory conditions?

Authors:  Claudio Marasca; Angelo Ruggiero; Maddalena Napolitano; Gabriella Fabbrocini; Matteo Megna
Journal:  Med Hypotheses       Date:  2020-05-19       Impact factor: 1.538

6.  Effectiveness of Online vs In-Person Care for Adults With Psoriasis: A Randomized Clinical Trial.

Authors:  April W Armstrong; Cindy J Chambers; Emanual Maverakis; Michelle Y Cheng; Cory A Dunnick; Mary-Margaret Chren; Joel M Gelfand; David J Wong; Brittany M Gibbons; Caitlin M Gibbons; Josefina Torres; Andrea C Steel; Elizabeth A Wang; Caitlin M Clark; Sanminder Singh; Heather A Kornmehl; Reason Wilken; Aleksandra G Florek; Adam R Ford; Chelsea Ma; Nazanin Ehsani-Chimeh; Sucharita Boddu; Mayumi Fujita; Paulina M Young; Cesar Rivas-Sanchez; Brenda I Cornejo; Laura C Serna; Eric R Carlson; Christianne J Lane
Journal:  JAMA Netw Open       Date:  2018-10-05
  6 in total
  3 in total

1.  Long-Term Efficacy and Safety of Guselkumab for Moderate to Severe Psoriasis: A 3-Year Real-Life Retrospective Study.

Authors:  Matteo Megna; Luca Potestio; Gabriella Fabbrocini; Angelo Ruggiero
Journal:  Psoriasis (Auckl)       Date:  2022-07-14

2.  Pemphigus vulgaris and COVID-19 vaccination: Management and treatment.

Authors:  Fabrizio Martora; Teresa Battista; Paola Nappa; Gabriella Fabbrocini; Matteo Megna
Journal:  J Cosmet Dermatol       Date:  2022-09-09       Impact factor: 2.189

3.  Comment on 'Morphoea following COVID-19 vaccination'.

Authors:  Fabrizio Martora; Teresa Battista; Angelo Ruggiero; Gabriella Fabbrocini; Luca Potestio
Journal:  Clin Exp Dermatol       Date:  2022-09-02       Impact factor: 4.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.